Spineology Inc.,the innovator in anatomy-conserving spine surgery, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants.
“Spineology is committed to developing the implant solutions our customers desire”
The Rampart line will include a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs. The Rampart System is further configured with implantation equipment designed to enhance the surgeon's ability to position the implant within the disc space.
"Spineology is committed to developing the implant solutions our customers desire," said John Booth, CEO for Spineology. "Rampart is a great synergistic fit for our growing product line."
Breakthrough obesity treatments on the horizon, rivaling surgery's success